Down-regulation of bax-interacting factor-1 in colorectal adenocarcinoma

Cancer

Volumn 113, Issue 10, 2008, Pages 2665-2670

  Coppola, Domenico ^a   Khalil, Farah ^a   Eschrich, Steven A ^a   Boulware, David ^a   Yeatman, Timothy ^a   Wang, Hong Gang ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Bif 1; Colon adenocarcinoma; Immunohistochemistry; Microarray

Indexed keywords

AVIDIN; BAX INTERACTING FACTOR 1; BIOTIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY BAX INTERACTING FACTOR 1; PEROXIDASE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER STAGING; CARCINOGENESIS; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE MICROARRAY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER; TISSUE ARRAY ANALYSIS;

EID: 55849126198     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23892     Document Type: Article

References (37)

1. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin. 2002;52:23-47.
2. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43-66.
3. Nishisho I, Nakamura Y, Miyoshi Y, et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science. 1991;253:665-669.
4. Rupnarain C, Dlamini Z, Naicker S, Bhoola K. Colon cancer: genomics and apoptotic events. Biol Chem. 2004;385:449-464.
5. Nechushtan A, Smith CL, Lamensdorf I, Yoon SH, Youle RJ. Bax and Bak coalesce into novel mitochondria-associated clusters during apoptosis. J Cell Biol. 2001;153:1265-1276.
6. Wei MC, Zong WX, Cheng EH, et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science. 2001;292:727-730.
7. Ming L, Wang P, Bank A, Yu J, Zhang L. PUMA Dissociates Bax and Bcl-X(L) to induce apoptosis in colon cancer cells. J Biol Chem. 2006;281:16034-16042.
8. Aita VM, Liang XH, Murty VV, et al. Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21. Genomics. 1999;59:59-65.
9. Liang XH, Jackson S, Seaman M, et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature. 1999;402:672-676.
10. Liang C, Feng P, Ku B, et al. Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG. Nat Cell Biol. 2006;8:688-699.
11. Cuddeback SM, Yamaguchi H, Komatsu K, et al. Molecular cloning and characterization of Bif-1: a novel SH3 domain-containing protein that associates with Bax. J Biol Chem. 2001;276:20559-20565.
12. Takahashi Y, Karbowski M, Yamaguchi H, et al. Loss of Bif-1 suppresses Bax/Bak conformational change and mitochondrial apoptosis. Mol Cell Biol. 2005;25:9369-9382.
13. Takahashi Y, Coppola D, Matsushita N, et al. Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesis. Nat Cell Biol. 2007;9:1142-1151.
14. Lee JW, Jeong EG, Soung YH, et al. Decreased expression of tumour suppressor Bax-interacting factor-1 (Bif-1), a Bax activator, in gastric carcinomas. Pathology. 2006;38:312-315.
15. Raff MC. Social controls on cell survival and cell death. Nature. 1992;356:397-400.
16. Green DR. Apoptotic pathways: the roads to ruin. Cell. 1998;94:695-698.
17. Vaux DL, Korsmeyer SJ. Cell death in development. Cell. 1999;96:245-254.
18. Reed JC. Mechanisms of Bcl-2 family protein function and dysfunction in health and disease. Behring Inst Mitt. 1996;(97):72-100.
19. Gozuacik D, Kimchi A. Autophagy as a cell death and tumor suppressor mechanism. Oncogene. 2004;23:2891-2906.
20. Ohsumi Y. Molecular dissection of autophagy: 2 ubiquitin-like systems. Nature Rev. 2001;2:211-216.
21. Levine B, Klionsky DJ. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell. 2004;6:463-477.
22. Pierrat B, Simonen M, Cueto M, Mestan J, Ferrigno P, Heim J. SH3GLB, a new endophilin-related protein family featuring an SH3 domain. Genomics. 2001;71:222-234.
23. Yamaguchi H, Paranawithana SR, Lee MW, Huang Z, Bhalla KN, Wang H-G. Epothilone B analogue (BMS-247550)-mediated cytotoxicity through induction of Bax conformational change in human breast cancer cells. Cancer Res. 2002;62:466-471.
24. Karbowski M, Jeong SY, Youle RJ. Endophilin B1 is required for the maintenance of mitochondrial morphology. J Cell Biol. 2004;166:1027-1039.
25. Shintani T, Klionsky DJ. Autophagy in health and disease: a double-edged sword. Science. 2004;306:990-995.
26. Mathew R, White E. Why sick cells produce tumors: the protective role of autophagy. Autophagy. 2007;3:502-505.
27. Green DR, Evan GI. A matter of life and death. Cancer Cell. 2002;1:19-30.
28. Bonner AE, Lemon WJ, Devereux TR, Lubet RA, You M. Molecular profiling of mouse lung tumors: association with tumor progression, lung development, and human lung adenocarcinomas. Oncogene. 2004;23:1166-1176.
29. Balakrishnan A, von Neuhoff N, Rudolph C, et al. Quantitative microsatellite analysis to delineate the commonly deleted region 1p22.3 in mantle cell lymphomas. Genes Chromosomes Cancer. 2006;45:883-892.
30. Walker GJ, Indsto JO, Sood R, et al. Deletion mapping suggests that the 1p22 melanoma susceptibility gene is a tumor suppressor localized to a 9-Mb interval. Genes Chromosomes Cancer. 2004;41:56-64.
31. Lee WC, Balsara B, Liu Z, Jhanwar SC, Testa JR. Loss of heterozygosity analysis defines a critical region in chromosome 1p22 commonly deleted in human malignant mesothelioma. Cancer Res. 1996;56:4297-4301.
32. Roberts T, Chernova O, Cowell JK. Molecular characterization of the 1p22 breakpoint region spanning the constitutional translocation breakpoint in a neuroblastoma patient with a t(1;10)(p22;q21). Cancer Genet Cytogenet. 1998;100:10-20.
33. Kakinuma H, Habuchi T, Ito T, et al. BCL10 is not a major target for frequent loss of 1p in testicular germ cell tumors. Cancer Genet Cytogenet. 2001;126:134-138.
34. Mora J, Cheung NK, Kushner BH, et al. Clinical categories of neuroblastoma are associated with different patterns of loss of heterozygosity on chromosome arm 1p. J Mol Diagn. 2000;2:37-46.
35. Emi M, Matsumoto S, Iida A, et al. Correlation of allelic losses and clinicopathological factors in primary breast cancers. Breast Cancer. 1997;4:243-246.
36. Bello MJ, de Campos JM, Vaquero J, Kusak ME, Sarasa JL, Rey JA. High-resolution analysis of chromosome arm 1p alterations in meningioma. Cancer Genet Cytogenet. 2000;120:30-36.
37. Knosel T, Petersen S, Schwabe H, et al. Incidence of chromosomal imbalances in advanced colorectal carcinomas and their metastases. Virchows Arch. 2002;440:187-194.